The tweet was deleted by the author.
But we saved everything 🙂.
REGENXBIO participated in the ASGCTherapy Annual Meeting, engaging with attendees and underscoring its commitment to advancing the field of gene therapy.
The company thanked collaborators and stakeholders who joined its team for in-depth conversations, reflecting a broader industry drive to push gene therapy innovation and research. Industry gatherings like this are instrumental for collaboration and exchanging new ideas that can accelerate the development of transformative therapies for genetic diseases.
REGENXBIO has previously recognized its administrative team for dedication and execution in achieving operational excellence within the company. The company stated that internal support contributes to ongoing success in its operations. Additional information is available in the company’s prior announcement.